HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

HMR 1426

an antiobesity agent; structure in first source

Also Known As:

HMR1426

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - HMR 1426: 1

Experts

1.	Bickel, Martin: 1 article (08/2004)
2.	Geisen, Karl: 1 article (08/2004)
3.	Gossel, Matthias: 1 article (08/2004)
4.	Jähne, Gerhard: 1 article (08/2004)
5.	Kampe, Juliane: 1 article (08/2004)
6.	Klaus, Susanne: 1 article (08/2004)
7.	Lang, Hans Jochen: 1 article (08/2004)
8.	Ortmann, Sylvia: 1 article (08/2004)

Related Diseases

1.	Weight Gain 08/01/2004 - "Chronic treatment with HMR1426 decreased weight gain by 31% and epididymal white fat by 24%. "
2.	Obesity 08/01/2004 - "Thus, HMR1426 can be considered a potential new drug for obesity treatment."
3.	Body Weight (Weight, Body) 08/01/2004 - "To determine the effect of acute and chronic administration of a new food intake-reducing compound (HMR1426) with novel mode of action (retardation of gastric emptying) on body weight development, food intake, and energy metabolism in rats. " 08/01/2004 - "HMR1426 showed an anorectic potential in rats and decreased body weight and fat mass. "

Related Drugs and Biologics

1.	Appetite Depressants (Anorectics)